TickerFactsScreenerDevelopers

Alaunos Therapeutics, Inc. (TCRT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$12.12M2010: -$24.55M2011: -$71.40M2012: -$102.17M2013: -$57.71M2014: -$43.50M2015: -$120.10M2016: -$165.31M2017: -$53.49M2018: -$53.91M2019: -$57.86M2020: -$80.36M2021: -$77.55M2022: -$35.10M2023: -$34.27M2024: -$4.81M2025: -$4.22M-$4.22M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$4.22M+12.2%
2024-$4.81M+86.0%
2023-$34.27M+2.4%
2022-$35.10M+54.7%
2021-$77.55M+3.5%
2020-$80.36M-38.9%
2019-$57.86M-7.3%
2018-$53.91M-0.8%
2017-$53.49M+67.6%
2016-$165.31M-37.6%
2015-$120.10M-176.1%
2014-$43.50M+24.6%
2013-$57.71M+43.5%
2012-$102.17M-43.1%
2011-$71.40M-190.9%
2010-$24.55M-102.5%
2009-$12.12M—